Intramyocardial injection of an MYDGF-loaded citrate-containing hydrogel in MI mice significantly reduced scar formation and infarct size, increased wall thickness and neovascularization, and improved cardiac function (Yuan et al. 2019). The gene discussed is MYDGF; the disease is myocardial infarction.